Amylx Pharmaceuticals Inc vs NetApp Inc. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while NetApp Inc. trades at $199.43 (market cap $38.95B). The key difference: NetApp Inc. is far larger — about 14.8× Amylx Pharmaceuticals Inc's market cap, and NetApp Inc. pays a 1.05% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | NTAP | |
|---|---|---|
Market Cap | $2.64B | $38.95B |
Sector | Health | Technology |
52-Week High | $24.19 | $198.72 |
52-Week Low | $7.82 | $94.11 |
Enterprise Value | $2.39B | $38.10B |
Dividend Yield | — | 1.05% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →